NovoArc GmbH
PrivateLast Round
Seed
Dec 9, 2024
Total Funding Raised
$1.2M
Company Overview
NovoArc GmbH is a biotechnology company that develops and manufactures lipid-based formulations to enable the oral delivery of drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovoArc GmbH Comparables
Compare NovoArc GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Particella | 81% | |
| Intract Pharma | 79% | |
| ACM Biolabs | 77% |
NovoArc GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 9, 2024 | ||||
| Seed | Feb 1, 2022 |
NovoArc GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Austria Wirtschaftsservice | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2024
$960K round led by Austria Wirtschaftsservice
- Feb 1, 2022
Completed a Seed funding round.
NovoArc GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NovoArc GmbH's valuation, stock price, and market status.
Is NovoArc GmbH a public or private company?
NovoArc GmbH is a private company.
What is the current stock price of NovoArc GmbH?
NovoArc GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is NovoArc GmbH worth (valuation)?
Valuation information for NovoArc GmbH is not publicly available.
Can I buy NovoArc GmbH stock?
NovoArc GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NovoArc GmbH's last funding round?
NovoArc GmbH's most recent funding round was Seed on December 9, 2024.
Who are the main investors in NovoArc GmbH?
Key investors in NovoArc GmbH include Austria Wirtschaftsservice.
Will NovoArc GmbH IPO soon?
No public IPO plans have been announced for NovoArc GmbH.
How can I track NovoArc GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NovoArc GmbH's secondary market activity and sign up for updates.